Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
Clinical trial NCT05639192 · TERMINATED
Trial details
- NCT number
- NCT05639192
- Sponsor
- Apogenix GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-03
- Primary completion
- 2023-08-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.